The US veterinary vaccines market, excluding foot and mouth vaccines, stood at $10.5 per capita in 2023 and is forecast to gradually increase, reaching $10.97 by 2028. Alternatively expressed, the year-on-year growth averages approximately 1.14%. A five-year compound annual growth rate (CAGR) suggests a consistent upward trend.
Future trends to watch include potential impacts of technological advancements in vaccine development, shifts in pet ownership and livestock management practices, and regulatory changes. Additionally, the focus on animal welfare and potential zoonotic disease outbreaks may further drive market demand.
